However, the broader research question whether GLP-1 drugs slow biological aging is relevant to: People already prescribed semaglutide for diabetes or obesity management who want to understand whether additional biological effects are possible Older adults and their clinicians exploring whether GLP-1 medications might serve additional preventive functions in aging People living with HIV , for whom accelerated biological aging is a documented clinical challenge Researchers in aging science , who are now actively pursuing follow-up trials in broader populations Adults with visceral obesity or metabolic syndrome , which share key biological pathways with the conditions studied in this trial It is important to note that semaglutide carries significant side effects for many people, including nausea, vomiting, and gastrointestinal discomfort

From Manual Tracking to Clinical Clarity: Optimizing GLP-1 Outcomes Most people manage this by manually writing notes or setting calendar alarms because it is familiar and low-friction
The different effect on the hydration status seen in our groups might have been caused by the different baseline hydration status as fluid retention tends to progress with renal impairment 34
Dive into our engaging exploration and discover how to navigate your path to healthier metabolic wellbeing
Financial Overview 11.3.1.4
Levothyroxine addresses thyroid hormone deficiencies, while semaglutide may enhance weight management, regulate appetite, and stabilize energy levels